The Weill Cancer Hub East has been established to explore the “interplay” between nutrition and immunotherapy in cancer ...

Tribune has secured $39.9m in seed and Series A funding for its therapy portfolio aimed at the central drivers of scar tissue ...

Genmab has received approval from Japan's Ministry of Health, Labour and Welfare for its Tivdak to treat cervical cancer.

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

A total of 29 new blockbuster-in-waiting drugs entered the late-stage pipeline in 2024, a jump from the previous year’s 19.

EU member states are set to launch the EU Health Data Space Regulation for harmonised data transfer on 26 March.

MSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to prevent invasive disease ...

MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral small molecule Lp(a) inhibitor, HRS-5346.

Sanofi will commence a Phase I/II trial with its vaccine candidate in the next few days to start generating immunogenicity ...

Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...

The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and ...

Today marks World TB Day 2025 with the WHO calling for more investment into TB treatment and research globally.